Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

nuclear factor kappa B

  • You have access
    Nitric Oxide Inhibits NF-κB-mediated Survival Signaling: Possible Role in Overcoming TRAIL Resistance
    JOSEPH A. BAUER, JOSEPH A. LUPICA, JOSEPH A. DIDONATO and DANIEL J. LINDNER
    Anticancer Research December 2020, 40 (12) 6751-6763; DOI: https://doi.org/10.21873/anticanres.14698
  • You have access
    The Combination of Nuclear Factor Kappa B, Cyclo-oxygenase-2 and Vascular Endothelial Growth Factor Expression Predicts Poor Prognosis in Stage II and III Colorectal Cancer
    NAM KYU KIM, JIN KYU PARK, EUNAH SHIN and YOUNG WAN KIM
    Anticancer Research November 2014, 34 (11) 6451-6457;
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire